JP2016504311A5 - - Google Patents

Download PDF

Info

Publication number
JP2016504311A5
JP2016504311A5 JP2015546770A JP2015546770A JP2016504311A5 JP 2016504311 A5 JP2016504311 A5 JP 2016504311A5 JP 2015546770 A JP2015546770 A JP 2015546770A JP 2015546770 A JP2015546770 A JP 2015546770A JP 2016504311 A5 JP2016504311 A5 JP 2016504311A5
Authority
JP
Japan
Prior art keywords
agent according
cells
stro
progeny
endothelial dysfunction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015546770A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016504311A (ja
JP6572130B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2013/001452 external-priority patent/WO2014089623A1/en
Publication of JP2016504311A publication Critical patent/JP2016504311A/ja
Publication of JP2016504311A5 publication Critical patent/JP2016504311A5/ja
Application granted granted Critical
Publication of JP6572130B2 publication Critical patent/JP6572130B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015546770A 2012-12-12 2013-12-12 内皮機能不全及び炎症の疾患の治療 Active JP6572130B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261736361P 2012-12-12 2012-12-12
US61/736,361 2012-12-12
PCT/AU2013/001452 WO2014089623A1 (en) 2012-12-12 2013-12-12 Treatment of diseases of endothelial dysfunction and inflammation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019123243A Division JP6829288B2 (ja) 2012-12-12 2019-07-01 内皮機能不全及び炎症の疾患の治療

Publications (3)

Publication Number Publication Date
JP2016504311A JP2016504311A (ja) 2016-02-12
JP2016504311A5 true JP2016504311A5 (https=) 2017-01-19
JP6572130B2 JP6572130B2 (ja) 2019-09-04

Family

ID=50933585

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2015546770A Active JP6572130B2 (ja) 2012-12-12 2013-12-12 内皮機能不全及び炎症の疾患の治療
JP2019123243A Active JP6829288B2 (ja) 2012-12-12 2019-07-01 内皮機能不全及び炎症の疾患の治療
JP2021008250A Active JP7201715B2 (ja) 2012-12-12 2021-01-21 内皮機能不全及び炎症の疾患の治療
JP2022206042A Pending JP2023030116A (ja) 2012-12-12 2022-12-22 内皮機能不全及び炎症の疾患の治療
JP2024111736A Pending JP2024147655A (ja) 2012-12-12 2024-07-11 内皮機能不全及び炎症の疾患の治療

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2019123243A Active JP6829288B2 (ja) 2012-12-12 2019-07-01 内皮機能不全及び炎症の疾患の治療
JP2021008250A Active JP7201715B2 (ja) 2012-12-12 2021-01-21 内皮機能不全及び炎症の疾患の治療
JP2022206042A Pending JP2023030116A (ja) 2012-12-12 2022-12-22 内皮機能不全及び炎症の疾患の治療
JP2024111736A Pending JP2024147655A (ja) 2012-12-12 2024-07-11 内皮機能不全及び炎症の疾患の治療

Country Status (11)

Country Link
US (2) US20160175360A1 (https=)
EP (2) EP3556850A1 (https=)
JP (5) JP6572130B2 (https=)
KR (3) KR102506612B1 (https=)
CN (2) CN111840329B (https=)
AU (4) AU2013360024B2 (https=)
CA (1) CA2893942C (https=)
ES (1) ES2742035T3 (https=)
IL (1) IL239308A0 (https=)
SG (2) SG11201504340YA (https=)
WO (1) WO2014089623A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5542686B2 (ja) 2007-12-04 2014-07-09 プロテオバイオアクティブズ・ピーティーワイ・リミテッド 前駆細胞の保護およびその分化の調節
SG11201504340YA (en) * 2012-12-12 2015-07-30 Mesoblast Inc Treatment of diseases of endothelial dysfunction and inflammation
JPWO2022114111A1 (https=) * 2020-11-27 2022-06-02

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
WO1992001070A1 (en) 1990-07-09 1992-01-23 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce High efficiency packaging of mutant adeno-associated virus using amber suppressions
US5173414A (en) 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
JP3534749B2 (ja) 1991-08-20 2004-06-07 アメリカ合衆国 アデノウイルスが介在する胃腸管への遺伝子の輸送
ATE530180T1 (de) * 1997-04-02 2011-11-15 Brigham & Womens Hospital Verfahren zur ermittlung der individualen risikoprofile atherosklerotischen erkrankungen
AU2003901668A0 (en) * 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
AUPQ147799A0 (en) 1999-07-07 1999-07-29 Medvet Science Pty. Ltd. Mesenchymal precursor cell
DE19939781C2 (de) 1999-08-21 2003-06-18 Schott Glas Skulltiegel für das Erschmelzen oder das Läutern von anorganischen Substanzen, insbesondere von Gläsern und Glaskeramiken
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
CA2866468C (en) 2004-09-24 2019-09-03 Mesoblast, Inc. Generating multipotential expanded mesenchymal precursor cell progeny (memp) from mesenchymal progenitor cells (mpc) and stimulation factor
WO2006108229A1 (en) 2005-04-12 2006-10-19 Angioblast Systems, Inc. Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
JP2008544957A (ja) * 2005-05-10 2008-12-11 ユナイテッド ステイツ オブ アメリカ デパートメント オブ ヴェテランズ アフェアーズ 間充織幹細胞による腎疾患及び多臓器不全の治療法と間充織幹細胞馴化培地
US20080260703A1 (en) * 2007-04-23 2008-10-23 Medistem Labortories Treatment of Insulin Resistance and Diabetes
WO2009073616A2 (en) * 2007-11-30 2009-06-11 New York Medical College Compositions comprising vascular and myocyte progenitor cells and methods of their use
US8124071B2 (en) * 2007-11-30 2012-02-28 New York Medical College Methods of reducing transplant rejection and cardiac allograft vasculopathy by implanting autologous stem cells
JP5542686B2 (ja) * 2007-12-04 2014-07-09 プロテオバイオアクティブズ・ピーティーワイ・リミテッド 前駆細胞の保護およびその分化の調節
JP2011526892A (ja) * 2008-06-30 2011-10-20 アンジオブラスト システムズ,インコーポレーテッド 併用療法を使用した眼疾患及び過剰血管新生の治療
EP2350266B1 (en) * 2008-11-20 2015-07-29 Mesoblast, Inc. Method for treating or preventing a pancreatic dysfunction
WO2010138180A2 (en) * 2009-05-26 2010-12-02 The University Of Vermont And State Agriculture College Compositions and methods for cardiac tissue repair
WO2011073521A1 (en) * 2009-12-15 2011-06-23 Petri Salven Methods for enriching adult-derived endothelial progenitor cells and uses thereof
WO2012047733A2 (en) * 2010-09-29 2012-04-12 Aidan Research And Consulting, Llc. Treatment of acne by conditioned media
US9405700B2 (en) 2010-11-04 2016-08-02 Sonics, Inc. Methods and apparatus for virtualization in an integrated circuit
WO2012162754A1 (en) * 2011-06-03 2012-12-06 Mesoblast, Inc Methods of treating or preventing neurological diseases
KR101786862B1 (ko) * 2011-07-04 2017-10-18 메소블라스트, 아이엔씨. 류마티즘성 질환을 치료 또는 예방하는 방법
CA2880808C (en) * 2012-08-01 2023-01-24 United Therapeutics Corporation Treatment of pulmonary arterial hypertension with mesenchymal stem cells
SG11201504340YA (en) * 2012-12-12 2015-07-30 Mesoblast Inc Treatment of diseases of endothelial dysfunction and inflammation
JP6431850B2 (ja) * 2013-01-09 2018-11-28 ユナイテッド セラピューティクス コーポレイション プロスタサイクリンおよび間葉系幹細胞による脈管障害の処置

Similar Documents

Publication Publication Date Title
Van Dijk et al. The complex mural cell: pericyte function in health and disease
Sinha et al. 5-Lipoxygenase as a drug target: A review on trends in inhibitors structural design, SAR and mechanism based approach
Tousoulis et al. Endothelial dysfunction in conduit arteries and in microcirculation. Novel therapeutic approaches
JP2013523152A5 (https=)
CL2013003331A1 (es) Tableta de liberacion inmediata a prueba de alteracion que comprende (i) una matriz, y (ii) una pluralidad de material particulado, que comprende un opiaceo y un polimero de oxido de polietileno de mas de 20.000 g/mol, donde el multiparticulado forma una fase discontinua dentro de la matriz.
JP2012530141A5 (https=)
JP2014508138A5 (https=)
JP2018505158A5 (https=)
PH12018500261B1 (en) Azole benzene derivative
JP2016504311A5 (https=)
JP2016502980A5 (https=)
Jain et al. Antihypertensive drugs aliskiren, nebivolol, and olmesartan reduce hypertension by reducing endothelial microparticles and regulating angiogenesis
JP2012515165A5 (https=)
WO2010091051A3 (en) Therapeutic use of specialized endothelial progenitor cells
JP2014533256A5 (https=)
CN103550755B (zh) 一种氟苯尼考硫酸粘菌素可溶性粉及其制备方法
JP2011527984A5 (https=)
JP2018510917A5 (https=)
RU2014145827A (ru) Композиция, включающая амлодипин и лозартан, имеющая улучшенную стабильность
RU2010153426A (ru) Объемная тканеинженерная конструкция "лиоматрикс"
WO2021057061A1 (en) Senolytic and antiinflammatory prodrugs and methods of use thereof
CN104398525B (zh) 闭花木酮的o-(哌嗪基)乙基衍生物在制备抗慢性阻塞性肺病药物中的应用
RU2018110607A (ru) Фармацевтическая композиция для предотвращения и лечения заболеваний печени, содержащая в качестве активного ингредиента кромолин или его фармацевтически приемлемую соль
CN106008560B (zh) 一种双小檗碱衍生物的制备方法和用途
CN104622883B (zh) 用于治疗动脉粥样硬化的药物制剂及其制备方法